{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.135",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2021-03-06T01:00:16.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.135",
  "version": "20210306",
  "name": "Dolasetron Oral",
  "status": "active",
  "date": "2021-03-06T01:00:16-05:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "310006",
            "display": "dolasetron 100 MG Oral Tablet"
          },
          {
            "code": "310007",
            "display": "dolasetron 50 MG Oral Tablet"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:73355503-800a-4c34-942d-373a44923f4e",
    "timestamp": "2022-06-10T07:10:56-04:00",
    "total": 2,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "code": "310006",
        "display": "dolasetron 100 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "code": "310007",
        "display": "dolasetron 50 MG Oral Tablet"
      }
    ]
  }
}